Dong-Seok Yim

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Venues

Translational and clinical pharmacology

Pharmaceutics

Drug design, development and therapy

Biopharmaceutics & drug disposition

Catholic University of Korea School of Medicine

Seoul National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Catholic University of Korea School of Medicine Sep 01 2001

South Korea

Professor :: Pharmacology

Georgetown University Aug 01 2003 - Jul 30 2005

United States

International Fellow :: CDDS, Georgetown Medical Center

Education History

Seoul National University Mar 02 1992 - Feb 14 1996

South Korea

PHD :: Clinical Pharmacology

Publications

Suein Choi, Dong-Seok Yim, Soo Hyeon Bae
Prediction of metabolizing enzyme-mediated clinical drug interactions using in vitro information. Translational and clinical pharmacology 30 (1) (2022)
Dong-Seok Yim, Soo Hyeon Bae, Suein Choi
Predicting human pharmacokinetics from preclinical data: clearance. Translational and clinical pharmacology 29 (2) (2021)
Dong-Seok Yim, Suein Choi
Predicting human pharmacokinetics from preclinical data: volume of distribution. Translational and clinical pharmacology 28 (4) (2020)
Suein Choi, Sangil Jeon, Dong-Seok Yim, Seunghoon Han
Contribution of Trough Concentration Data in the Evaluation of Multiple-Dose Pharmacokinetics for Drugs with Delayed Distributional Equilibrium and Long Half-Life. Drug design, development and therapy 14 (2020)
Choon-Ok Kim, Sangil Jeon, Seunghoon Han, Min Soo Park, Dong-Seok Yim
A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519. Pharmaceutics 12 (6) (2020)
Dong-Seok Yim, Suein Choi, Soo Hyeon Bae
Predicting human pharmacokinetics from preclinical data: absorption. Translational and clinical pharmacology 28 (3) (2020)
Suein Choi, Seunghoon Han, Sangil Jeon, Dong-Seok Yim
Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP). Pharmaceutics 11 (7) (2019)
Dong-Seok Yim
Author's response to letter to the editor on: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. Biopharmaceutics & drug disposition 38 (7) (2017)

Dong-Seok Yim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dong-Seok Yim